Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 14, 2014; 20(42): 15608-15615
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15608
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15608
Laparoscopic resection of gastrointestinal neuroendocrine tumors with special contribution of radionuclide imaging
Andreas Shamiyeh, Ludwig Boltzmann Institute for Operative Laparoscopy and 2nd Surgical Department, Linz General Hospital, 4020 Linz, Austria
Michael Gabriel, Department of Nuclear Medicine and Endocrinology, Linz General Hospital, 4020 Linz, Austria
Michael Gabriel, University Clinic of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria
Author contributions: Shamiyeh A and Gabriel M equally contributed to this paper.
Correspondence to: Andreas Shamiyeh, MD, Ludwig Boltzmann Institute for Operative Laparoscopy and 2nd Surgical Department, Linz General Hospital, Krankenhausstrasse 9, 4020 Linz, Austria. shamiyeh@akh.linz.at
Telephone: +43-732-78062133 Fax: +43-732-78062198
Received: January 15, 2014
Revised: March 22, 2014
Accepted: May 23, 2014
Published online: November 14, 2014
Processing time: 305 Days and 21.2 Hours
Revised: March 22, 2014
Accepted: May 23, 2014
Published online: November 14, 2014
Processing time: 305 Days and 21.2 Hours
Core Tip
Core tip: The level of evidence for the role of laparoscopy for gastrointestinal neuroendocrine tumors (NET) is low. There is a lack of randomised trials. The authors searched for relevant literature for Net and laparoscopy as well as laparoscopic surgery for gastrointestinal malignancies. This paper provides a recent update for minimal invasive treatment for NET and included the pre- and postoperative management. In particular, this article also showed the value of radionuclide imaging for treatment stratification and management of these patients based on the overexpression of somatostatin receptors in the tumor.